-->

Tag: AAV9 SMN1 therapy

Home / AAV9 SMN1 therapy

Categories

GC101 Gene Therapy for Spinal Muscular Atrophy Type 1 – Phase I/II Clinical Trial

Gene Therapy for Spinal Muscular Atrophy Type 1 – Phase I/II Clinical Trial ClinicalTrials.gov Identifier: NCT05824169Sponsor: GeneCradle Inc.Study Title: Safety and Efficacy of GC101 Gene Therapy i...
aav9-smn1-therapy

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients

GC101 Gene Therapy for Spinal Muscular Atrophy Type 2 – Phase I/II Clinical Trial ClinicalTrials.gov Identifier: NCT05901987Sponsor: GeneCradle Inc.Study Title: Safety and Efficacy of GC101 Gene The...
aav9-smn1-therapy

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients

Phase III Trial: GC101 Gene Therapy for Type 2 Spinal Muscular Atrophy (SMA) ClinicalTrials.gov Identifier: NCT06971094Sponsor: GeneCradle Inc.Study Title: Safety and Efficacy Evaluation of GC101 Gen...
aav9-smn1-therapy

Scan the code